Veraxa Biotech AG - Post de-SPAC VRXA
NASDAQ VRXA
$1.15 -0.04 (-3.36%)
As of: Oct 2, 2026 · 9:38 AM EDT

Veraxa Biotech AG - Post de-SPAC (VRXA) Non-Current Assets (2024 - 2025)

Updated

Veraxa Biotech AG - Post de-SPAC's Non-Current Assets was $97.51 million in the quarter ended Dec 31, 2025, up 7.9% from $90.36 million a year earlier.

Analysis

Veraxa Biotech AG - Post de-SPAC (VRXA) Non-Current Assets (2024 - 2025) Analysis & Trends

As of Dec 31, 2025, Non-Current Assets at Veraxa Biotech AG - Post de-SPAC came in at $94 million, up 4.5% from the prior year.

  • In earlier years, Non-Current Assets was $89.98 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 141.29 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 101.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 87.87 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 35.42 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 14.88 Bn
10 Veraxa Biotech AG - Post de-SPAC 18.09 Mn 14.68 Mn - 97.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 97.51 Mn
Dec 31, 2024 90.36 Mn
API Access

Veraxa Biotech AG - Post de-SPAC Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=VRXA&period=max&api_key=YOUR_API_KEY